Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India

被引:14
作者
Goyal, Mohit [1 ]
Patil, Pravin [2 ]
Pathak, Himanshu [3 ]
Santhanam, Sham [4 ]
Goel, Anshul [5 ]
Sharma, Vishnu [6 ]
Pandey, Akshat [7 ]
Gupta, Nikhil [8 ]
Jain, Rahul [9 ]
Akerkar, Shashank [10 ]
Das, Parthajit [11 ,12 ]
Dudam, Rajkiran [13 ]
Mendiratta, Naval [14 ]
Pandey, Bimlesh Dhar [15 ]
Mithun, C. B. [16 ]
Singh, Bharat K. [17 ]
Kumar, Sharath [18 ]
Nolkha, Nilesh [19 ]
Jain, Shriyanka [20 ]
Jain, Somya [21 ,22 ]
Sharma, Ashish [15 ]
Misra, Durga Prasanna [23 ]
机构
[1] CARE Pain & Arthrit Ctr, Div Rheumatol, Udaipur, Rajasthan, India
[2] Apex Ctr Rheumatol, Pune, Maharashtra, India
[3] Tricolour Hosp, Dept Rheumatol, Vadodara, India
[4] Gleneagles Global Hosp, Dept Rheumatol, Chennai, Tamil Nadu, India
[5] Vivekanand Med Inst, Dept Rheumatol, Palampur, Himachal Prades, India
[6] Apollo Hosp Int Ltd, Dept Rheumatol, Ahmadabad, Gujarat, India
[7] Apollo Hosp, Dept Rheumatol, Indore, India
[8] Ctr Arthrit & Rheumatol Dis, Delhi, India
[9] Narayana Multispecialty Hosp, Dept Rheumatol, Jaipur, Rajasthan, India
[10] Mumbai Arthrit Clin, Mumbai, Maharashtra, India
[11] Apollo Gleneagles Hosp, Dept Rheumatol, Kolkata, India
[12] Vivekananda Inst Med Sci, Dept Rheumatol, Kolkata, India
[13] Hyderabad Rheumatol Ctr, Hyderabad, India
[14] Fortis Mem Res Inst, Dept Rheumatol, Gurgaon, India
[15] Fortis Hosp, Div Rheumatol, Noida, India
[16] Amrita Inst Med Sci, Dept Clin Immunol & Rheumatol, Kochi, India
[17] Santokba Durlabhji Mem Hosp, Dept Rheumatol & Clin Immunol, Jaipur, Rajasthan, India
[18] OPTIMA Arthrit & Rheumatol Clin, Bengaluru, India
[19] Wockhardt Hosp, Mumbai, Maharashtra, India
[20] Ram Krishna Care Hosp, Div Rheumatol, Raipur, Madhya Pradesh, India
[21] AKJ Healthcare & Diagnost, Dept Rheumatol, Saharanpur, India
[22] Max Super Special Hosp Dehradun, Dept Rheumatol, Dehra Dun, Uttarakhand, India
[23] Sanjay Gandhi Post Grad Inst Med Sci, Dept Clin Immunol & Rheumatol, Lucknow, Uttar Pradesh, India
关键词
communicable diseases; systemic; glucocorticoids; hydroxychloroquine; imported lupus erythematosus; autoimmune diseases;
D O I
10.1136/annrheumdis-2020-218013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 5 条
[1]  
Kaul R., 2016, HINDUSTAN TIMES
[2]   Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro [J].
Liu, Jia ;
Cao, Ruiyuan ;
Xu, Mingyue ;
Wang, Xi ;
Zhang, Huanyu ;
Hu, Hengrui ;
Li, Yufeng ;
Hu, Zhihong ;
Zhong, Wu ;
Wang, Manli .
CELL DISCOVERY, 2020, 6 (01)
[3]   Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine [J].
Mathian, Alexis ;
Mahevas, Matthieu ;
Rohmer, Julien ;
Roumier, Mathilde ;
Cohen-Aubart, Fleur ;
Amador-Borrero, Blanca ;
Barrelet, Audrey ;
Chauvet, Cecile ;
Chazal, Thibaud ;
Delahousse, Michel ;
Devaux, Mathilde ;
Euvrard, Romain ;
Fadlallah, Jehane ;
Florens, Nans ;
Haroche, Julien ;
Hie, Miguel ;
Juillard, Laurent ;
Lhote, Raphael ;
Maillet, Thibault ;
Richard-Colmant, Gaelle ;
Palluy, Jean Baptiste ;
Pha, Micheline ;
Perard, Laurent ;
Remy, Philippe ;
Riviere, Etienne ;
Sene, Damien ;
Seve, Pascal ;
Morelot-Panzini, Capucine ;
Viallard, Jean-Francois ;
Virot, Jean-Simon ;
Benameur, Neila ;
Zahr, Noel ;
Yssel, Hans ;
Godeau, Bertrand ;
Amoura, Zahir .
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (06) :837-+
[4]   COVID-19: consider cytokine storm syndromes and immunosuppression [J].
Mehta, Puja ;
McAuley, Daniel F. ;
Brown, Michael ;
Sanchez, Emilie ;
Tattersall, Rachel S. ;
Manson, Jessica J. .
LANCET, 2020, 395 (10229) :1033-1034
[5]  
Press Information Bureau, UPD NOV COR ON POS C